232 related articles for article (PubMed ID: 20838386)
1. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.
Ishiyama K; Katagiri T; Hoshino T; Yoshida T; Yamaguchi M; Nakao S
Bone Marrow Transplant; 2011 Jun; 46(6):863-9. PubMed ID: 20838386
[TBL] [Abstract][Full Text] [Related]
2. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
[TBL] [Abstract][Full Text] [Related]
3. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
[TBL] [Abstract][Full Text] [Related]
4. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.
Ogata M; Satou T; Kawano R; Goto K; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Saikawa T; Kadota JI
Bone Marrow Transplant; 2008 Feb; 41(3):279-85. PubMed ID: 18037945
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
[TBL] [Abstract][Full Text] [Related]
7. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation.
Mori Y; Miyamoto T; Nagafuji K; Kamezaki K; Yamamoto A; Saito N; Kato K; Takenaka K; Iwasaki H; Harada N; Abe Y; Teshima T; Akashi K
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1596-602. PubMed ID: 20685258
[TBL] [Abstract][Full Text] [Related]
8. [Human herpesvirus 7 infection in patients after allogeneic hematopoietic stem cell transplantation].
Wang LR; Dong LJ; Lu DP
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2113-6. PubMed ID: 17988530
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.
Ogata M; Kikuchi H; Satou T; Kawano R; Ikewaki J; Kohno K; Kashima K; Ohtsuka E; Kadota J
J Infect Dis; 2006 Jan; 193(1):68-79. PubMed ID: 16323134
[TBL] [Abstract][Full Text] [Related]
10. Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation.
Kamble RT; Clark DA; Leong HN; Heslop HE; Brenner MK; Carrum G
Bone Marrow Transplant; 2007 Sep; 40(6):563-6. PubMed ID: 17637686
[TBL] [Abstract][Full Text] [Related]
11. Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation.
Vittayawacharin P; E'Leimat G; Lee BJ; Griffin S; Doh J; Nam H; Blodget E; Jeyakumar D; Kongtim P; Ciurea SO
Transplant Cell Ther; 2023 Jun; 29(6):397.e1-397.e6. PubMed ID: 36878429
[TBL] [Abstract][Full Text] [Related]
12. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
Tormo N; Solano C; de la Cámara R; Garcia-Noblejas A; Cardeñoso L; Clari MA; Nieto J; López J; Hernández-Boluda JC; Remigia MJ; Benet I; Navarro D
Biol Blood Marrow Transplant; 2010 May; 16(5):653-61. PubMed ID: 20005968
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis.
Shimazu Y; Kondo T; Ishikawa T; Yamashita K; Takaori-Kondo A
Transpl Infect Dis; 2013 Apr; 15(2):195-201. PubMed ID: 23331378
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients.
Wang FZ; Larsson K; Linde A; Ljungman P
Bone Marrow Transplant; 2002 Oct; 30(8):521-6. PubMed ID: 12379892
[TBL] [Abstract][Full Text] [Related]
16. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
[TBL] [Abstract][Full Text] [Related]
17. Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.
Ogata M; Takano K; Moriuchi Y; Kondo T; Ueki T; Nakano N; Mori T; Uoshima N; Nagafuji K; Yamasaki S; Shibasaki Y; Sakai R; Kato K; Choi I; Jo Y; Eto T; Kako S; Oshima K; Fukuda T
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1264-1273. PubMed ID: 29454651
[TBL] [Abstract][Full Text] [Related]
18. [Human Herpesvirus-6 Encephalitis in Allogeneic Hematopoietic Stem Cell Transplantation].
Ogata M
Brain Nerve; 2015 Jul; 67(7):919-30. PubMed ID: 26160819
[TBL] [Abstract][Full Text] [Related]
19. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation.
Sakai R; Kanamori H; Motohashi K; Yamamoto W; Matsuura S; Fujita A; Ohshima R; Kuwabara H; Tanaka M; Fujita H; Maruta A; Ishigatsubo Y; Fujisawa S
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1389-94. PubMed ID: 21296175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
